
|Articles|December 18, 2010
Clarification
We at OTEurope previously ran a headline stating "Lucentis receives DME approval in the EU". For the purpose of clarification, this referred to CHMP approvals alone. Full acceptance for Lucentis in Europe will require approval from EMEA.
Advertisement
We at OTEurope previously ran a headline stating, "Lucentis receives DME approval in the EU". For the purpose of clarification, this referred to CHMP approvals alone. Full acceptance for Lucentis in Europe will require approval from EMEA.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
4
Port Delivery System Therapies in Retinal Vascular Diseases
5






















